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ABSTRACT 
 
Prediction of fetal DNA allows diagnosing known/passed mutations before child’s birth. Public 
health significance of such early testing is that it can reassure parents who have negative results 
and offers timely information for those with abnormal results. 
My dissertation work presents a new approach of reconstructing fetal DNA from 
maternal plasma. The method works because plasma from pregnant women, which contains 
“cell-free DNA”, has been noted to contain fetal DNA as well as maternal DNA. I developed and 
tested a workflow that implements my suggested approach. The workflow was broken into 
several parts, each fully documented in this dissertation. Each step we have taken was supported 
with explanation of the logic driving the step. The approach works through the examination of 
sequencing data sets generated by short-read sequencing (also known as next-generation 
sequencing), by calling variation (single nucleotide polymorphisms, or SNPs) within those 
samples vis-à-vis a reference sequence. I developed and introduced a series of quality control 
criteria applied to SNPs to improve overall prediction. A novel single individual haplotyping 
method was developed and applied to haplotype the parental samples. The obtained parental 
haplotypes were incorporated into the workflow and along with parental genotypes were used to 
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find transmitted haplotypes in the maternal plasma. The predicted haplotypes were then aligned 
to each other to obtain phased SNPs. For evaluation, I compared fetal SNPs predicted by my 
method against control fetal SNPs (from sequencing of fetal DNA). Overall prediction power is 
discussed. Possible ways of improvements that should affect the overall prediction are also 
described. 
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1.0  INTRODUCTION 
1.1 BACKGROUND AND SIGNIFICANCE 
The current dissertation work is based on a phenomenon known as “cell-free DNA”. During a 
pregnancy, cell-free DNA from the fetus can be found in the maternal blood plasma, such that 
DNA prepared from maternal blood plasma will contain both fetal and maternal DNAs 1-5 In 
theory, knowing the DNA sequence of the parents (only mother or both parents), one could 
predict fetal DNA sequence from the cell-free DNA of the plasma. This method is very unique. 
First of all it allows prediction of fetal DNA sequence during the early stages of the pregnancy 
and to diagnose genetic abnormalities if any exist. Secondly, cell-free fetal DNA testing is 
noninvasive because it requires only a maternal blood sample. It means that, compared to 
invasive methods like chorionic villus sampling (CVS) or amniocentesis, the method does not 
increase the risk of miscarriage. Thirdly, it can be used starting as early as the 9-10th week of 
pregnancy, which is much earlier than conventional invasive methods mentioned. CVS and 
amniocentesis are usually done at 10-12 and 15-18 weeks, respectively 6. On the other hand 
predicting fetal DNA from cell-free DNA of the maternal plasma also has limitations, especially 
because it is fundamentally a prediction based on probability. The accuracy of the prediction 
depends on many factors, for example, the timing of the test. The concentration of fetal DNA in 
the maternal blood plasma increases throughout the pregnancy, which makes detecting fetal 
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DNA easier and then predicting the fetal DNA sequence more accurate as the pregnancy 
progresses. In the early stages of the pregnancy the concentration of fetal DNA in the mother’s 
blood plasma is very low. This means that, in order to make a valid prediction that can be 
utilized for counseling, one must balance the timing of the test vs. the accuracy of the 
information gathered – the longer one waits, the more accurate the prediction, but fewer options 
remain to manage the consequences of the obtained information. Furthermore, although the test 
can be performed using only mother’s blood sample, for better performance additional testing of 
paternal DNA samples is required, which increases the price of the test. When paternal DNA is 
not available for ethical or other reasons, it becomes difficult to predict the alleles inherited from 
the father. It is conceivable that, when technologies advance making genetic testing more precise 
and less expensive, the limitations mentioned above will become less relevant. 
Finally, the scale of the genetic polymorphism of interest is another factor that affects the 
accuracy. The bigger the DNA change we are looking for, the more exact the prediction we get. 
Consequently, predicting inherited chromosomal abnormalities like aneuploidies is 
straightforward1-3. This method is becoming very popular and is actively being integrated into 
clinical practice. Starting in 2011, at least 4 companies have offered clinical tests based on cell-
free fetal DNA to predict inherited aneuploidies of chromosomes 13, 18, and 21. The price for 
any one such test was arbitrary; it varied from $200 to $235. One of the companies claimed that 
during the year 2012 they performed 60,000 tests 7. 
We can also predict smaller changes such as single nucleotide polymorphisms (SNPs) 4 
as well as small insertions and deletions (indels). By looking for small differences in the 
coverage of tested alleles we can even identify (possibly) which allele was inherited from which 
parent. Next-generation sequencing methods are great in this regard in terms of their simplicity; 
 2 
they give a faster and cheaper means of scanning broad regions of the genome with high 
sensitivity. However they suffer from some limitations that need to be worked on. For example 
because of the vast number of identified SNPs, the rate of finding false positive results due to 
random chance is also high. Increased level of significance and p-value adjustment for multiple 
testing may solve part of the issue; nevertheless it also decreases the sensitivity of the test. 
Furthermore, due to the inherited stochasticity of the experimental process used in sequencing 
technology, the number of times a specific SNP is sequenced (coverage, depth) may greatly vary, 
which may bias the prediction of inherited alleles. In order to increase accuracy, one could 
additionally use laboratory-based methods of whole genome haplotyping 8-10, however this 
would mean additional lab work. The idea of the cell-free DNA method is based on the fact that 
a child inherits only one haploid set of chromosomes from each parent. By generating haplotypes 
of the parents, we are then able to determine which parental haplotypes were passed to the child 
4. It means that we will be able to assign inheritance of the alleles as groups, but not individually. 
Analytically, there are multiple methods for analyzing maternal plasma sequence data. 
One method described by Christina Fan et al 11 starts with individual sequencing and whole 
genome haplotyping (Kitzman et al 9) of both parents. With that data in hand, it proceeds by 
determining which allele was passed on to the fetus at loci which are maternal-only heterozygous 
(i.e. loci where the mother is heterozygous, but the father is homozygous), and then doing the 
same prediction for paternal-only heterozygous sites (where the father is heterozygous, but the 
mother is homozygous). Using this information it determines the haplotypes that were passed on 
to the fetus. Next, the method will predict transmission at sites that are heterozygous for both 
parents for sites situated in the same haplotype blocks that are maternal-only or parental-only 
heterozygous sites (Figure 1). Finally, one can predict sites with apparent de novo mutations 
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(when the offspring appears heterozygous, while both parents are homozygous and are identical) 
4. 
 
 
Figure 1. Haplotype based prediction. 
 
Another method starts with whole genome haplotyping of both parents. Then they assess 
each SNP in every haplotype block and identify which allele was transmitted to the fetus. 
However the method does not assign inherited alleles for individual SNPs, but for whole 
haplotype block. It identifies the haplotype that has greater number of SNPs that support the 
inheritance pattern, and then corrects the rest of the SNPs within that haplotype block 12. 
Both methods depend on haplotype technologies. Haplotypes are constructed for parents 
and assumed to be the same for offspring. However haplotypes may change due to 
recombination and the SNPs within a haplotype after the breakpoint will be wrongly predicted. 
Another weakness of the approaches is that they omit any variants for which parental haplotypes 
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are not available. They also require ultra-deep sequencing of maternal plasma to enable practical 
detection of fetal de novo mutations due to low specificity. 
As mentioned above haplotype information is critical for fetal DNA prediction. Based on 
literature research there are several approaches to obtain haplotype information: (1) population 
genotype data; (2) population sequenced fragment data; and (3) single individual sequenced 
fragments data. We use later approach in current work to increase the accuracy of our prediction. 
Kitzman et al. introduced haplotype-resolved genome sequencing 9. They physically chop 
the whole genome and clone the pieces; combine them into pools so each contains approximately 
~3% physical coverage of the diploid human genome; sequence those and finally use maximum 
parsimony approach 13 to combine unphased variant calls with haploid genotype calls to 
assemble haplotype blocks. 
Lancia et al. introduced another method called individual SNP haplotype reconstruction 
14 that can be performed purely on sequenced fragments and does not require additional 
laboratory work as the method mentioned above. It can be described in a following way. The 
fragments obtained by DNA sequencing originate from two copies of a chromosome and based 
on the SNP values observed in the sequenced fragments we could sort them into two groups that 
represent two haplotypes (Figure 2). If we denote sequenced fragments as nodes and draw a 
connection between two nodes (fragments) only if they carry different alleles for a particular 
SNP, then haplotype reconstruction becomes simply solving a network problem, in particular 
constructing bipartite graphs, where nodes are divided into two sets and connections exist 
between nodes of different sets, but not within a set (Figure 3). In error-free scenario this task is 
a matter of computational time. However, due to the nature of the experiments in molecular 
biology there are always some errors that need to be corrected before your data become 
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consistent with the existence of two haplotypes. Then depending on optimization approach, the 
problem may turn into minimum fragment removal (MFR) 14, minimum SNP removal (MSR) 14, 
longest haplotype reconstruction (LHR) 14, and minimum error correction (MEC) 15. This process 
is computationally intensive and as soon as we allow gaps in the sequenced fragments the 
problem becomes considerably more complex. A fragment has a gap when the SNPs {i,i+1, … 
i+k} it covers do not have values, while SNPs {m, m+1 … i-1} and {i+k+1, i+k+2, … n} where 
m < i < n and ݇ א {0, 1, 2 … } does. The data I have in current study came from paired end 
sequencing, which means that fragments are sequenced from both ends and have some gap when 
those fragments do not connect. 
 
 
Figure 2. Single individual haplotyping. 
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 Figure 3. Networking problem. 
 
Dynamic programming can be used to approach the problems 16-22. However does not 
allow to solve the four models effectively in general case, which is HP-hard (Non-deterministic 
Polynomial-time hard). Better performance can be obtained using heuristic algorithms 13, 23-29. 
In this current work, we will define a workflow for fast and accurate prediction of fetal 
DNA sequence from maternal plasma sequencing data. We will develop and apply a novel 
analytical method to understand sequence data from an 8 Mbp region from a chromosome 12, 
allowing us to predict the fetal genotypes from the maternal plasma sequence data. For 
confirmation, we also have available the sequence data from the father, from the mother (core 
blood) and from the fetus (CVS). We will use modern methods to obtain haplotype information 
using a computational approach and avoid additional lab work saving time and money spent on 
making the test. 
 
 7 
1.2 PUBLIC HEALTH RELEVANCE 
Prediction of fetal DNA allows diagnosing known/passed abnormalities (mutations) before 
child’s birth. Earlier testing has many benefits. It can reassure parents who have negative results. 
For those with abnormal results it offers timely information to help them make difficult 
decisions. If they choose to continue a pregnancy, they will have additional time to prepare to 
deliver and care for their child. 
Our method is categorized as noninvasive, which is risk-free for miscarriage. 
Haplotyping improves overall prediction accuracy and obtaining haplotype information 
computationally improves the timing, which also affects the cost of the test. We suggest a new 
approach of haplotyping that is done without using lab assistance and thus results in a 
significantly reduced cost. 
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2.0  METHODS 
2.1 CREATING THE SNP DATABASE 
In current work we attempted to predict fetal genotypes from cell-free DNA in maternal plasma. 
For this purpose we assessed and sequenced DNA samples from both parents using their blood 
(excluding the plasma part) and obtained sequencing information from cell-free DNA in 
maternal plasma. The gestational age at which we got the mother’s blood was approximately 
~11.2 weeks. A month later we got cultured cells that were received from an amnio procedure 
and extracted pure fetal DNA, which then was used as a control for predicted genotypes. The 
karyotype for the baby was 46, XY. All of our sequencing data came from a hiseq2000. The 
sequencing data was from a sure select capture of an 8 Mbp region on chromosome 12 with the 
approximate coordinates at 22,456,231-30,651,071. 
We used GATK tools and followed the best practice 30 provided on their website to 
process sequencing data and produce a set of SNPs for all of the available DNA samples. In 
order to evaluate quality of the SNPs first we focused on SNPs that are available for whole trio, 
both parents and a child (fetus). By knowing genotypes of both parents and a child we were able 
to use a simple recombination rule to find troublesome SNPs, i.e. those that have several possible 
genotypes. Then we tried different filtering criteria to reduce the number of troublesome SNPs 
and used final cutoff values for quality control step. 
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Actual fetal DNA prediction was made based on positions of the maternal SNPs because 
DNA from plasma mainly consists of maternal DNA and we tried to develop method that does 
not rely on, but additionally improve accuracy when paternal DNA information is available. 
We did not genotype DNA samples from maternal plasma because general genotyping 
methods assume existence of two alleles for each SNP and they are distributed with allelic ratio 
around 50/50. However plasma contains DNA from two origins (maternal and fetal), 
consequently some SNP might have more than 2 alleles. The DNA proportion in the plasma is 
greatly shifted towards maternal DNA and half of the fetal DNA is inherited from mother, which 
further complicates variant discovery. For all SNPs in the database we searched directly 
sequencing data of maternal plasma and obtained allelic count and coverage of those positions. 
SNPs that had less than 20 sequencing fragments (coverage) in the plasma were excluded from 
further analysis. 
Knowing maternal genotypes and allelic distribution from the plasma we were able to 
find SNPs, discordant in these two samples. Assuming that majority of plasma DNA had 
maternal origin we should observe allelic distribution close to homozygous for any homozygous 
maternal SNPs and observe allelic distribution close to heterozygous for any heterozygous 
maternal SNPs. SNPs that in our opinion did not follow this logic were also excluded from 
further analysis. If fetal D1A in the plasma present as İ then the plasma should consist of 
maternal homozygous allele in 100-İ/ (if fetus is heterozygous) or  (if fetus is homozygous) 
percentages. Any maternal homozygous allele that had maternal homozygous allele frequency 
less than 70% in the plasma was excluded from the analysis. Likewise maternal heterozygous 
allele should have following percentages in the plasma 50-İ/2, 50, or 50+İ/. If major allele 
frequency was greater than 80% then that SNP was also excluded from the analysis. 
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The final step in our workflow was to reconstruct haplotypes for both parents (section 
2.2) and use this information in prediction of fetal DNA (section 2.3) 
2.2 HAPLOTYPE RECONSTRUCTION 
The normal individual has two copies of each chromosome. In every SNP we can be either 
homozygous, carrying the same allele, or heterozygous, carrying different alleles. Since 
homozygous SNPs do not carry information, necessary to distinguish between two haplotypes, 
we reconstructed haplotypes based on only heterozygous SNPs. In order to simplify formulation 
of the problem we replaced four-letter alphabet of the alleles {A, T, C, G} with binary notation, 
where 0 and 1 represented minor and major alleles respectively. With a new notation a SNP 
content of a chromosome become a string over the alphabet {0,1}. 
The basic framework for a SNP problem was introduced by Lancia et. al. 14, where he 
thought of a data as m×n matrix over the alphabet {0,1,-}, where each row corresponded to a 
fragment and each column corresponded to a SNP site. Then M[i,j] denoted the SNP allele of the 
ith fragment and jth SNP site. Whenever the allele was not available the M[i,j] = ‘-‘. All SNPs 
were sorted by positions from left to right and fragments were sorted by their starting positions 
from top to bottom. Using this data representation, we introduced the approach we have taken. 
The haplotype reconstruction was divided into two steps. The first step was to divide the 
initial SNP matrix into smaller matrices in a way that each smaller matrix represented a set of 
SNPs that were connected with fragments. In other words any two adjacent SNP within a smaller 
matrix were covered by at least one fragment. While between these sets of SNPs (smaller 
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matrices) the length of fragments were not enough to cover two adjacent SNPs and connection 
was disrupted. The step we were taking may be formulated as follows: 
Given two adjacent columns X = {x1, … xm} and Y = {y1, … ym}, where m is a number of 
fragments, ݔ௜  ܽ݊݀ ݕ௜ א {0,1,െ}, and Dj is defined as formula (1) 
 
ܦ = σ ݀(ݔ௜,ݕ௜)௠௜ୀଵ         (1) 
where 
݀(ݔ,ݕ) = ൜1,    (ݔ ݋ݎ ݕ)  ് ᇱ െ Ԣ,0,    ݋ݐ݄݁ݎݓ݅ݏ݁.     (2)  
 
For j = {2 …,n} we get a vector of numbers {D2, …, Dn}. If we cut the vector whenever 
Dj < p (where p is a minimum number of fragments, that cover two adjacent SNPs), then we 
receive a set of smaller vectors such as {Do, …, Do+k}, where k is a number of consecutive times 
Dj  p. If we divide the initial SNP matrix into smaller ones based on the rule introduced above, 
then the final matrices can be represented as M’l,k. Where l is a number of unique fragments that 
cover SNPs {so-1, …, so+k}. The reduced matrix will contain at least two SNPs and at least p 
fragments. In current work we used p=10. 
The second step of haplotype reconstruction approach was actually calculating haplotype 
blocks from reduced matrices. Every two SNPs can be combined in a way that gives four 
possible haplotypes {(0,0), (0,1), (1,0), (1,1)} or two pairs of complementary haplotypes {(0,0), 
(1,1)} and {(0,1), (1,0)}. If reduced SNP matrix contains k SNPs, then there are 2k-1 possible 
haplotype pairs (HPs). We calculated frequencies of all possible HPs and chose the most 
frequent HP for further analyses. The step we have taken to calculate frequencies of HPs can be 
formulated as follows. For each SNP pair there are four possible haplotypes or two 
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complementary haplotype pairs. H is proportion of fragments covering these two SNPs that 
supported a particular HP. 
 ଴  =  σ݀(ݔ௜,ݕ௜) +  σ݀(1 െ ݔ௜ , 1 െ ݕ௜)  
 ଵ  =  σ݀(ݔ௜, 1 െ ݕ௜) + σ݀(1 െ ݔ௜ ,ݕ௜)    (3) 
where 
 ݀(ݔ,ݕ) = ൜1,     ݔݕ ݏݑ݌݌݋ݎݐݏ ܽ ݌ܽݎݐ݅ܿݑ݈ܽݎ  ܪܲ0,    ݋ݐ݄݁ݎݓ݅ݏ݁.    (4)  
where ݔ௜  ܽ݊݀ ݕ௜  ܽݎ݁ ܵܰܲ ݒ݈ܽݑ݁ݏ א {0,1}, i={1,…,l}, and l is a number of fragments 
covering SNPs x and y. Then a frequency of a particular HP would be: 
݂ = ς  ௝௞௝ୀଶ         (5) 
After calculating the frequencies of all possible HP we would get F = {f1, …, f2k-1}, where 
k is a number of SNPs covered in a reduced Matrix. Whatever HP has max(fi) was taken for 
further analyses. 
The majority of the haplotype blocks were error free and concordant with only one HP. 
As an example below we present a HP that covered 6 consecutive heterozygous SNPs and had 
been calculated from 430 fragments: 
 
haplo block length: 6 
number of reads: 430 
positions: 22465632 22465638 22465698 22465775 22465814 22466013 
1 ['GCCCCA', 'TGATTG', 1.0] 
 
Another good example was the following HPs that had been calculated from a reduced 
matrix with 10 consecutive heterozygous SNPs and 1115 fragments. As we can see due to errors 
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there were 8 HPs and all of them except one had very low frequencies. From this data it was 
obvious that HP ('TGCCGGTGGG', 'GAAAAACTAT') with frequency 0.986 had huge advantage over 
other HPs and could be considered to be the true haplotype. 
 
haplo block length: 10 
number of reads: 1115 
positions: 23037386 23037417 23037435 23037453 23037486 23037531 23037558 
23037587 23037607 23037623 
1 ['TGCCGGTGGG', 'GAAAAACTAT', 0.986] 
2 ['TGCAAACTAT', 'GAACGGTGGG', 0.006] 
3 ['TGAAAACTAT', 'GACCGGTGGG', 0.003] 
4 ['TGCCGGTTAT', 'GAAAAACGGG', 0.002] 
5 ['TGCCGGTGAT', 'GAAAAACTGG', 0.002] 
6 ['TGACGGTGGG', 'GACAAACTAT', 1.818e-05] 
7 ['TGCAAACGGG', 'GAACGGTTAT', 1.400e-05] 
8 ['TGCAAACTGG', 'GAACGGTGAT', 1.336e-05] 
 
However some of the reduced matrices gave less obvious results. For example, the 
following HPs had been calculated from a reduced matrix with 4 consecutive heterozygous SNPs 
and 165 fragments. The most frequent HP did not have obvious advantage compared to others. 
The ratio between the most and the second most frequent HP was 4.69. But if we ignore the first 
SNP, then the rest of the SNPs in both HPs are concordant. 
 
haplo block length: 4 
number of reads: 165 
positions: 24206118 24206121 24206171 24206438 
1 ['CTTT', 'ACCC', 0.756] 
2 ['CCCC', 'ATTT', 0.161] 
3 ['CTCC', 'ACTT', 0.068] 
4 ['CCTT', 'ATCC', 0.015] 
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 In order to overcome this problem we introduced a simple condition in our calculation. 
When calculating h (formula 3), the number of fragments that supported a single HP, we 
assessed the ratio (r) of the two possible HPs. Whenever r>q we introduced a break into the HP, 
in other cases we ignored the HP with the least count. In current work we used q=0.1. 
ݎ = ௠௜௡( ೣ, భషೣ)
௠௔௫( ೣ, భషೣ)   where ݔ א {0,1}   (5) 
As a result the same reduced matrix from previous example gave two possible HPs with 
fewer SNPs, but more satisfying difference in frequencies. 
 
haplo block length: 3 
number of reads: <165 
positions: 24206121 24206171 24206438 
1 ['TTT', 'CCC', 0.917] 
2 ['TCC', 'CTT', 0.083] 
 
This simple condition of checking r also solved another problem. Due to inevitable 
errors, the more SNPs and fragments the reduced matrix contained, the more number of possible 
HPs with low frequencies we got. For example from a reduced matrix that covered 11 
consecutive heterozygous SNPs and 1065 fragments we observed 61 HPs. In this particular 
example the highest frequency was still very low and the haplotypes from this reduced matrix 
was ignored even though it contained 11 SNPs. 
 
haplo block length: 11 
number of reads: 1065 
positions: 26832732 26832753 26832769 26833052 26833117 26833247 26833448 
26833495 26833497 26833503 26833523 
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1 ['CCAAATCAGTT', 'TTCGTCTGAAC', 0.165] 
2 ['CCAAATCAAAC', 'TTCGTCTGGTT', 0.099] 
3 ['CCAAATCAGAC', 'TTCGTCTGATT', 0.097] 
4 ['CTCGTCTGAAC', 'TCAAATCAGTT', 0.059] 
. 
. 
. 
60 ['CTAATCTGAAT', 'TCCGATCAGTC', 1.096e-05] 
61 ['CCCGATCAATC', 'TTAATCTGGAT', 1.071e-05] 
 
Among all possible HPs, for further analyses we were using only one HP with the highest 
frequency. By ignoring low HP ratios and breaking haplotypes whenever HP ratio was too high, 
we were able to track only successive haplotypes and saved computational time and memory 
required for calculation. Finally the reduced matrix from previous example gave us two HPs with 
desired confidence. 
 
positions: 26833247 26833448 26833495 26833497 
[ATCA, TCTG, 1.0] 
 
positions: 26833503 26833523 
[TT, AC, 1.0] 
 
It is worth to mention that we showed an example where reduced matrix covered 11 SNP 
and gave 61 possible HPs. In our final haplotype table we were able to calculate haplotype 
blocks that covered 14, 19 and 20 SNPs in mom’s, dad’s and fetal samples respectively. If we 
did not ignore low frequent HP and did not break haplotypes, those haplotypes would cover over 
100 SNPs and calculated frequencies would be so low, that without special treatment during the 
calculation, the program would crash. 
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2.3 PREDICTION OF THE INHERITED SNPS 
We have two potential approaches to predict the inherited SNPs. First one is to modify already 
existing methods described by Fan et al. 11 or similar to it (discussed in section 1.1). These 
methods are greatly relying on haplotype information that is obtained by routine lab work. We 
may improve this step by using computational approach to reconstruct haplotypes from a SNP 
matrix of both parents. This is an intuitive way of predicting fetal DNA using plasma DNA 
samples. However with current data in hand we are not able to get much from it. Haplotyping of 
both parents allowed us to phase majority of the SNPs for each sample. And even less SNPs that 
have haplotype information from both parents at the same time. Most of the haplotype blocks 
connected only two SNPs, which means that prediction based on haplotype information has a 
marginal advantage from individual SNP based prediction. Attempting to predict inherited alleles 
based on individual SNPs is error prone. 
The second and main approach we want to focus on is to haplotype SNPs obtained from 
plasma samples. To my knowledge haplotyping DNA samples that have mixed origin has not 
been attempted. Current haplotyping methods assume existence of only two haplotypes, which 
are also complementary to each other and appears in equal amounts in the sample. DNA from 
plasma is a mixture of mother’s and fetal DNA, which present in the plasma in shifted 
proportion. The amount of mother’s DNA present in plasma exceeds fetal DNA by 
approximately 10 fold. Furthermore, half of the fetal DNA is inherited from mother, which 
means that theoretically we are looking at 3 possible haplotypes with expected proportion 
somewhat close to 50/45/5. The way we look at haplotype reconstruction problem allows us to 
deal with the main feature of the plasma sample, the existence of 3 haplotypes with shifted 
proportions.  
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Prediction of the inherited SNPs was made based on finding inherited maternal and 
paternal haplotypes. First, data from plasma was searched for any possible haplotypes consistent 
with available SNP matrices and then amount of short sequenced fragments that supports those 
haplotypes was calculated. From the pool of possible haplotypes we determined two of them that 
most likely were passed to the fetus. Finally predicted inherited haplotypes were used to 
reconstruct phased fetal SNPs. 
2.3.1 Constructing a pool of possible haplotypes 
Similar to single individual (parental) haplotype reconstruction first we transformed aligned 
short sequencing fragments into a set of small SNP matrices. Where SNPs within a matrix were 
connected to each other through fragments (described in section 2.2). We made fetal SNPs 
prediction based on each small matrix separately (Figure 4a). Every SNP matrix contained a set 
of SNPs S = {s1, … sn} and a set of fragments F = {f1, … fm}. Fragments were sorted in a way 
that every next fragment fj+1 had equal or more gaps from the left side compared to previous 
fragment fj. 
The reconstruction of possible haplotypes started from assigning the first fragment f1 to 
the first newly created haplotype h1. If next f2 overlapped with existing h1 and had the same value 
on the overlapped region, we extended h1 with values from f2. Otherwise another h2, equal to f2, 
was created. We repeated that process for the rest of the fragments and obtained a set of all 
possible branching haplotypes (Figure 4b). In order to complete haplotypes, created later during 
the reconstruction we repeated reconstruction of haplotypes with reverse ordered fragments and 
took previously obtained haplotypes as an initial pool of existing haplotypes.  
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a) An example of a SNP matrix with 3 SNPs and 5 fragments;  
b) Possible haplotypes reconstructed from the SNP matrix; 
Figure 4. SNP Matrix. 
 
Finally in the obtained pool of haplotypes if there were overlapping and concordant to 
each other haplotypes, they were also merged together to assure that constructed haplotypes were 
complete and did not contain any duplicates. 
2.3.2 Finding inherited maternal haplotype 
After obtaining a pool of possible haplotypes we attempted to find inherited maternal haplotypes. 
In order to assure finding of maternal haplotypes we scanned all possible haplotypes and 
removed those not consistent with available maternal genotypes or haplotypes. This procedure 
served us as the first filtering criteria. The next step was to calculate a set of A = {a1, … an} that 
corresponded to an amount of fragments that supported each haplotype F = {f1, … fn}. Every 
fragment was mapped against a set of potential maternal haplotypes and the amount of all 
identical fragments was distributed proportionally among all haplotypes that covered that 
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fragment. In other words for every fragment (fj) we got a temporary set of B = {b1, … bn} 
calculated by following formula: 
ܾ௜ = ௧೔ௌ ௝ܿ         (6) 
where  
ݐ௜ = ൜ܽ௜,     ݂݅ ݅௧  ݄ܽ݌݈݋ݐݕ݌݁ ܿ݋ݒ݁ݎݏ ݐ݄݁ ݂ݎܽ݃݉݁݊ݐ0,    ݋ݐ݄݁ݎݓ݅ݏ݁   
 ܵ = σ ݐ௜௡௜ୀଵ    
And cj corresponds to an amount of identical fragment fj. 
Finally calculated B was added to A or ai = ai + bi and calculation of B was carried for 
the rest of the fragments in the SNP matrix. There were several potential issues that needed to be 
addressed. Firstly, in order to successfully initiate the algorithm each element of the set A was 
assigned 1 (a1 = a2 = … =an =1) and subtracted 1 after completing the calculation. Secondly, the 
order with which fragments are fed to the algorithm mattered. Performing calculations 100 times 
with randomly ordered fragments and averaging the resulting number we overcame mentioned 
problem. 
Another step in a way of finding maternal haplotypes was to group them into 
complementary pairs. Taking into account that maternal DNA was prevalent in the plasma and 
that both maternal haplotypes must be present, it was safe to assume that the two complementary 
haplotypes, as well as the most frequent haplotypes were maternal haplotypes. In single 
individual two haplotypes should be present in equal amount (or close to equality), but in the 
plasma there should be three haplotypes: maternal not passed, maternal passed and paternal 
passed. If fetal DNA concentration in the plasma present as İ then the three haplotypes should be 
present in the plasma in following proportions (percentages) 50-İ/  İ/ respectively 
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Following this logic it was clear that whichever maternal haplotype had more supporting 
fragments (more abundant) was the one passed from mother. 
It is important to mention that when possible haplotypes were grouped into 
complementary pairs it became possible to merge some of the haplotypes. In some cases two 
non-overlapping haplotypes were both complementary to a single haplotype. Even though there 
was no fragment linking those two haplotypes, due to the complementarity to a single haplotype 
they were still thought as one and merged in the process. Due to described actions a number of 
haplotypes were merged together, which reduced diversity of haplotypes for certain SNP 
matrices. In order to be more accurate in prediction after merging haplotypes we recalculated an 
amount of fragments that supported each haplotype and for second time predicted inherited 
maternal haplotype. 
2.3.3 Finding inherited paternal haplotype 
In order to find inherited paternal haplotype first we constructed allele count matrix. Where 
columns and rows represent SNP positions and alleles respectively (Figure 5.1). The data was 
taken directly from short read library (bam file). At this point we already knew both maternal 
haplotypes and decided which one of them was passed to the child. We hypothesized that when 
counts from the alleles that maternal haplotypes hold were removed the remaining allele counts 
matrix had contained some leftovers from which we were potentially able to calculate paternal 
haplotype. 
In the example below there is an allele count matrix with 5 SNPs and Figure 5.1 presents 
allele counts for those SNP positions. There are also two maternal haplotypes GCCCC and 
TGATT, where haplotype MH1 was passed to the child. From the corresponding SNP matrix we 
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calculated number of fragments that covered each allele in both haplotypes. The next step was to 
remove those alleles that were covered by maternal haplotypes and then to calculate sum of 
allele counts for each possible haplopytes consistent with paternal genotypes or haplotypes 
(when available). It happened that for this particular example there were only two possible 
haplotypes exactly the same as maternal haplotypes. When we simply subtracted numbers and 
calculated the sum of allele counts in each possible haplotypes, we still got fairly big numbers 
(Figure 5.2). We suspected that the reason was that maternal haplotypes were most abandoned in 
the plasma and we removed alleles that were linked in the fragments but not those that were 
separately presented in the data. Those leftovers from maternal haplotypes still presented in big 
amount that clouded further selection. In order to overcome this issue we had to subtract alleles 
from haplotypes proportionally.  
 
1) Allele count; 2) Allele count after haplotype allele count substructed; 
Figure 5. Allele count matrix. 
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One of the suggested ways was to substitute subtraction by division in the equation. The 
resulting numbers are shown in Figure 5.3 When we summed resulted numbers for each 
haplotype we got 7,722 and 7,436 for haplotypes GCCCC and TGATT respectively, which 
looked more comparable to each other. There is one more advantage of this approach. If there 
was another possible haplotype the resulting sum of allele count for that haplotypes would be in 
the same scale as both maternal haplotypes. For example haplotype TGACC would have allele 
count 7,358. 
After finding both haplotypes passed to the child it is fairly easy to reconstruct fetal SNPs. When 
both haplotypes are aligned against each other and SNP positions were tracked we got predicted 
phased fetal SNPs. 
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3.0  RESULTS 
3.1 MERGING DATASETS AND QUALITY CONTROL 
Sequencing data from all samples were processed using GATK best practice 30. Sequencing 
fragments was mapped and aligned against human whole genome version 19 (HG19). Any 
sequencing reads mapped to other than region of interests (chr12:22,456,000-30,652,000) were 
excluded from the further analysis. The number of remaining reads and the average coverage 
among all samples is shown in the Table 1. Mother, father and baby had 11887, 11180 and 
10646 unfiltered raw SNPs respectively.  
 
Table 1. Summary statistics of the datasets. 
Sample Name Plasma Mom Dad Baby 
Number of reads per sample 194 098 096 71 257 336 42 351 442 63 573 642 
Percentage of trimmed reads 9.72% 6.37% 5.94% 6.13% 
Number of reads mapped to a 
region of interest 
3 542 547 1 988 443 1 739 474 1 838 167 
Number of variants per sample 
(total) 
- 11887 11180 10646 
Number of variants per sample 
(after filtering) 
- 10535 10764 10298 
Average SNP coverage  170 155.7 163.7 
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Called SNPs from whole trio (both parents and the fetus) were merged together to create 
a list of SNPs that all three of them shared. The rational for that was to scan the SNPs and find 
obvious mismatches and develop a rule for Quality Control (QC) filtering. In total there were 
9376 common SNPs (Table 2). Knowing genotypes of both parents and the fetus we were able to 
find fetal SNPs that could not be obtained from any possible recombination of parental alleles. 
For example heterozygous fetal SNPs (Aa) should be left from the analysis if both parents were 
homozygous by major allele (AA). There were 73 examples of that kind of SNPs. Manually 
examining those SNPs we noticed that a majority of them had either low Depth (total coverage) 
or low Allelic Ratios (AR), a proportion of allele frequencies. The same as Allelic Depth, that 
indicates level of confidence with which SNP is called, the AR is also important. In general we 
expect both alleles for heterozygous SNP to be in equal amount, which gives AR close to 1. 
However due to stochasticity of the experimental process used in sequencing technology AR 
may greatly vary. In order to justify the choice, filtering value for AR was selected based on 
binomial distribution. For every Depth value we calculated two tailed 99% CI of the proportion 
(AR) and used the lower bound value. Table 2 shows filtering values and number of errors and 
total SNPs left after filtering. 
 
Table 2. Quality Control values for filtering by coverage and ratio. 
Filtering values Passed filtering 
Depth Allele Ratio Errors SNPs 
- - 73 9376 
7 0.15 17 7636 
9 0.17 10 7281 
12 0.2 5 6970 
15 0.22 3 6764 
20 0.25 3 6530 
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We filtered out SNPs with depth < 12 and AR < 0.2. As you can see after applying these 
filtering values the final dataset contained 6970 SNPs with only 5 errors. In our opinion those 
were optimal values for thresholds because compared to previous row the number of errors 
reduce 2 fold and further strengthening of threshold values did not bring much improvement, but 
did increase loss of data. Further analysis confirmed that chosen depth and AR cutoff values 
were selected properly. The same AR value was used by Panconesi et. al. where the authors tried 
to reconstruct haplotypes from single individual SNPs and treated as homozygous any SNP that 
had Allelic Ratio lower than 0.2 23. Another reason for not using very strict filtering thresholds is 
that we could also loose potential fetal mutations. After applying filtering values number of 
SNPs for each sample slightly reduced which is shown in Table 1. 
For the purpose of fetal DNA prediction we decided to use all maternal but not only 
common SNPs shared by all family members. There were 10535 maternal SNPs and only 6970 
of them in other family members too. 
All SNPs from the dataset were queried to search allelic coverage in sequencing data 
from plasma sample. Some of the SNPs were poorly sequenced in plasma sample. Any SNPs 
that had sequencing depth less than 20 reads (we used more strict threshold for plasma sample) 
were excluded from the analysis. We were able to find allelic information for 7358 SNPs with 
required sequencing depth. 
During the process of directly accessing the sequencing data we encountered another 
criteria for quality control, so called Mapping Quality (mapq). Mapping Quality showed how 
good any sequenced fragment had been mapped to the reference. Based on our observation it was 
decided to not rely on any fragment with mapq < 20 (data not shown). Mapq = 20 means that 
there is 0.01 chance to mistakenly map the read. Experience showed that applying more strict 
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value for mapq  (< 40) resulted in lost of too many sequencing fragments and many heterozygous 
SNPs did not show the second allele (became homozygous). Furthermore such reduction of reads 
directly affected very important variable Allelic Ratio. 
Finally 159 SNPs were removed from the dataset. 12 of them were homozygous in the 
mother, but clearly heterozygos in the plasma and other way around 147 of them were 
heterozygous in the mother, but had homozygous signature in the plasma. Final SNP dataset 
contained 7199 SNPs that were then used for fetal DNA prediction. 
3.2 RECONSTRUCTION OF PARENTAL HAPLOTYPES 
In every sample a total set of SNPs called for that particular sample separately, but not SNPs of 
merged datasets, was used to reconstruct haplotypes. During merging the datasets many of the 
SNPs were not called in all samples and were filtered out. Those SNPs could potentially be 
connecting links between haplotype blocks and so were considered important for haplotype 
reconstruction. For each sample we prepared individual set of SNPs positions. Any SNPs that did 
not pass QC were excluded from the haplotype reconstruction. Also all homozygous SNPs were 
removed because they did not distinguish haplotypes (this was due to the approach used in 
current work, which was different from other published methods 23, 29, 31, 32). The developed 
approach is explained in detail in Section 2.2. For mom, dad and fetus we have reconstructed 
1037, 1008 and 923 separate haplotype blocks respectively (Table 3). The majority 71.46% of 
mom’s haplotype blocks had the size of 2 SNPs. The 66.17% of dad’s haplotype blocks and 
65.9% of fetal haplotype blocks were also just pairs of SNPs. Fetus had the biggest reconstructed 
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haplotype block that linked 20 SNPs. While the biggest haplotype block reconstructed from both 
mom and dad contained 14 and 19 SNPs respectively. 
 
Table 3. Summary statistics for haplotype block sizes. 
Variables Mom Dad Baby 
Min 2 2 2 
Q1 2 2 2 
Median 2 2 2 
Mean 2.514 2.669 2.791 
Q3 3 3 3 
Max 14 19 20 
size=2 (%) 71.46 66.17 65.9 
Total 1037 1008 923 
3.3 FETAL SNPS PREDICTION 
Actual fetal SNPs prediction was divided into 4 steps: building a set of individual SNP matrices, 
finding maternal haplotype, finding paternal haplotype and aligning both haplotypes to construct 
phased fetal SNPs. 
From the all SNP matrices that were obtained from the DNA from maternal plasma 364 
of them were removed from further analysis because the total number of fragments was less than 
10. The number of 10 was chosen arbitrarily and it will change if further analysis suggests more 
appropriate threshold. For the comparison 479, 545, 606 and 655 SNP matrices didn’t pass the 
condition when 20, 30, 40 and 50 were used as a threshold respectively. 
During the rest of the analysis 37 and 4 of the SNP matrices were additionally excluded 
from the analysis because they did not have enough information to determine maternal and 
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parental haplotypes respectively. Remaining 1463 SNP matrices contained enough information 
to calculate both inherited parental haplotypes and reconstruct fetal SNPs from those haplotypes. 
Nevertheless it is hard or even impossible to evaluate the accuracy of finding maternal and 
paternal haplotypes separately, but to evaluate them together by comparing predicted fetal SNPs 
to the control at the very end of the analysis. 
We expected the least problems on the second step, when maternal haplotype was 
chosen. Following basic assumption the haplotype that was passed to the child should be the 
most abundant in the plasma. That is why firstly we found both maternal haplotypes, then 
recalculated the number of fragments that supported each of the haplotypes and finally selected 
the one that present in most quantity. The mean and median of odd ratios between fragments 
counts that support passed and not passed maternal haplotypes were 1.72 and 1.36 respectively. 
The following statistics suits the assumption and further convinced us that inherited maternal 
haplotype was chosen based on well-justified algorithm. 
Finding inherited paternal haplotype was less obvious. It could differ from maternal 
haplotype and also partially or totally duplicate either one of the maternal haplotypes. And most 
importantly fragments that support paternal haplotypes were present in fewer amounts in the 
plasma. In order to find paternal haplotype firstly we removed those fragments that supported 
maternal haplotypes and then calculated allele based counts for all possible haplotypes using 
remaining SNP matrix. As was suggested previously we removed allele counts from maternal 
haplotype proportionally to the amount they were present in the plasma. The remaining allele 
count matrix was then used to calculate allele counts for all haplotypes concordant with both 
paternal genotypes and haplotypes (when available). We expected paternal haplotype to be next 
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most abundant in the plasma after removing maternal haplotypes. Following stated assumption 
we were able to find inherited paternal haplotypes for all, but for 4 SNP matrices. 
After knowing both parental haplotypes it became fairly easy to align them together to 
get phased fetal genotypes. The statistics for predicted fetal genotypes after comparing to the 
control are shown in Table 4. Surprisingly there were a number of incomplete haplotypes that 
resulted in 14 SNPs that were not predicted based on haplotype reconstruction. 4 of them also 
did not have available fetal genotypes, while 10 of them had. 137 SNPs had only one available 
allele. 44 of them could not be tested due to unavailable fetal genotypes, 13 did not match at all 
and 80 have only one match. There were predicted 860 SNPs without available control. The rest 
of the predicted SNPs had available both predicted and fetal genotypes. 46 of them did not 
match, 725 had only one match and 1142 matched both alleles. 
 
Table 4. Statistics for predicted fetal genotypes. 
Number of 
predicted 
alleles 
Number of 
available 
fetal alleles 
Number of 
matches 
Number of 
SNPs 
When sum of allele counts for inherited 
maternal haplotype was reduced 
-1.00 -5.00 /1.36 /1.72 
0 0 0 4 4 4 4 4 
0 2 0 10 10 10 10 10 
1 0 1 44 45 46 46 53 
1 2 0 13 13 17 16 16 
1 2 1 80 80 88 87 96 
2 0 2 860 860 858 858 851 
2 2 0 46 33 16 19 18 
2 2 1 725 675 650 655 633 
2 2 2 1142 1215 1243 1237 1251 
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It was surprise to find that some of the genotypes were missing. It is small portion 
compared to the rest of the SNPs, but we expect to reduce it even more once haplotype 
reconstruction is perfected. A whole different matter is that so many SNPs that had available 
both predicted and control fetal genotypes had only one matched allele. Our experience showed 
that maternal haplotype that was chosen as inherited were present in the plasma in such big 
concentration that it was picked secondly after removing both allele counts of maternal 
haplotypes from the allele count matrix. Meaning that that particular haplotype was assigned also 
as paternal haplotype and resulted in homozygous genotypes for all SNPs covered by that 
haplotype block. No wonder if child were heterozygous all of the SNPs in that region will have 
only one match. It also explains why some of the SNPs did not have any matches at all. 
A series of small adjustments for the condition when paternal haplotype was chosen were 
tried. Further reduction of a sum of allele counts for inherited maternal haplotype was applied in 
favor to other haplotypes to be picked as paternal one. We tried to subtract and divide to a series 
of coefficients and the results were steadily improving (Table 4). As you can observe whenever 
division was used the results where somewhat better. We suspect that it might happen because 
the total number of fragments in each SNP matrix greatly varied from 10 to over hundreds. 
Respectively the allele counts for possible haplotypes were also responding differently when 
allele counts of maternal haplotypes were removed. That is why simply subtracting a coefficient 
from a sum of allele counts of inherited maternal haplotype affected only some portion of the 
cases. The effect was much broader when divided to a coefficient because it reduced the sum 
proportionally to its magnitude. We are not claiming that it is the best approach, but it is a good 
hint towards wright direction. 
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4.0  DISCUSSION 
The sequencing data used in current work was from a sure select capture of an 8 Mbp region on 
chromosome 12. It was mapped and aligned against human whole genome (HG19) and then cut 
off to leave the sequencing fragments mapped only to the region of interest. Unfortunately after 
limiting the data to the region of interest less than 5% of the original raw data remained. In order 
to test another different approach alternatively raw sequencing data was mapped and aligned 
against only chromosome 12 of human genome and then used for variant calling. As a result we 
obtained slightly bigger amount of SNPs targeted to the region of interest, but the average 
coverage of those SNPs did not improve much. In order to make a comparison we searched for 
SNPs that were called in both scenarios. There were 7149 of such SNPs and the average 
coverage was 201.66 and 203.47 when mapped to whole genome and only to chromosome 12 
respectively. As you can see there is no benefit of limiting reference genome to only 
chromosome 12. It surely saves computational time, but miss important point. The data contains 
noise or sequenced fragments from other parts of genome. If data is forced to map against only 
chromosome 12, mistakenly mapped reads could alter the quality of called SNPs. On the other 
hand when mapped against whole genome actual reads from target region may mistakenly map 
to other chromosomes and be excluded from the analysis. Taking into the account that amount of 
SNPs and their average coverage did not change much and the purpose of this work is the 
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prediction of fetal DNA we decided to minimize the amount of noise included to the analysis and 
map against whole genome. 
In current work we developed and suggested two single individual haplotyping methods. 
First is done on parental DNA samples, the second on DNA from the plasma. Actually, the 
second haplotyping method can be thought as a slight improvement of the first one. It was 
adjusted to work with DNA from plasma, which is a mixture of DNAs sample from two origins. 
Single individual haplotyping method applied for parental samples has some similarities 
with already published haplotyping methods. For example, it relies on the same assumption of 
existence of two complementary haplotypes that could be reconstructed from overlapping 
fragments. Sequencing fragments need to be transformed into SNP matrices that later are used in 
the analysis separately. However the method developed in this dissertation has it’s own 
distinguishing differences. There are series of advantages of my method over published 
haplotyping methods. First it builds haplotypes that are consistent with available data. It 
predicted all possible haplotypes, counts the number of fragments that support each of the 
haplotypes and chooses only two complementary haplotypes that are most frequent and have 
clear advantage compared to other possible haplotypes. Second, it does not introduce any 
changes to the alleles. There are two ways of dealing with fragments that support alternative 
haplotypes: they are removed if their prevalence is too small compared to fragments that support 
main haplotypes and a breakpoint in haplotypes is introduced so the remaining data is consistent 
with existence of two but smaller haplotypes. Third, the published methods try to reconstruct two 
continuous (unbroken) haplotypes for whole SNP matrix. After any change in SNP matrix 
(removed SNP, fragment or changed allele) haplotypes are reconstructed again. The process is 
repeated until all possible changes are calculated. After that a minimum set changes that makes 
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data most consistent with existence of only two haplotypes is chosen. Consequently the 
computational time is increased exponentially for longer SNP matrices. In contrast, our method 
avoids such redundancy. It forces to make a decision either to continue haplotype or introduce a 
breakpoint for every next SNP. Less calculation results in faster performance. Our method with 
huge adjustment can be thought as MFR (minimum fragments removal approach). But fragments 
are excluded based on observed data, rather than searching for best set of fragments to ignore 
and recalculate entire process after any removal. Fourth, if data contains gaps the computation 
dramatically complicates when published methods are used. In proposed method we safely skip 
those gaps and keep computational time reasonable. 
Unfortunately, my haplotyping method remains some limitations that also common to 
published methods. In particular, it has limited application for fetal DNA prediction. Haplotype 
reconstruction is done on a SNP matrix, which contain interconnected SNPs. Any SNP that is not 
in the matrix is potentially lost or need to be predicted individually. From the data available at 
our disposal for each sample we were able to successfully group majority of all SNPs into 
matrices and use them to reconstruct haplotypes. However when both parental haplotypes 
aligned only half of phased SNP were common for both parents. Furthermore majority of the 
haplotypes had size of 2 SNPs, which had almost no advantage over individual SNP based 
prediction. On the other hand prediction based on too big haplotypes does not account for 
recombination. Parental haplotypes are reconstructed prior to recombination that may occur 
during the meiosis. Haplotype based prediction is strongly dependent on finding fetal DNA 
concentration in the plasma. For any data like ours that does not contain sequencing information 
for Y chromosome finding fetal DNA concentration is difficult challenge. Finally discussed 
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methods greatly rely on paternal DNA, which may not always be available for some ethical or 
other reasons. 
Our proposed method that predicts fetal DNA based on haplotyping directly from plasma 
avoids mentioned limitations and uses parental haplotypes as an additional step, but is not 
required. Previously data was searched for only two complementary haplotypes. The rest of 
possible haplotypes, that could contain the third paternal haplotype, were considered as a noise 
and were dropped out from the analysis. Our proposed method uses all available haplotypes and 
has a series of advantages: available paternal DNA sample is preferable, but not required; plasma 
usually is sequenced with great depth, which allows phasing more SNPs and obtaining longer 
haplotypes; haplotypes not only predicted, but quantitative measure is introduced to count 
fragments supporting each haplotype. It greatly improves the prediction and has potential useful 
in finding fetal DNA concentration in the plasma; and most importantly this method may be 
potentially applied to other samples with mixed DNAs. 
For example my method with some adjustments can be applied in cancer genetics. 
Mother become a host, fetus become a mutated cancer cells. The similarity between host and 
cancer DNAs are much greater compared to similarities between maternal and fetal DNAs, but it 
can be accounted for. As you can see in this scenario there is no paternal DNA to evaluate half of 
the cancer genome and no Y chromosome to calculate concentration of cancer DNA. My method 
allows to option in and out additional source of information like paternal DNA or Y chromosome 
to improve overall accuracy. Which makes it very flexible in practical application. 
Due to the stochasticity used in sequencing technologies some level of errors (wrong 
alleles) is always present. We constantly worked on reducing these errors by filtering SNPs that 
not consistent with parental genotypes and removing sequenced fragments that also not 
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consistent with either genotypes or haplotypes of the parents. This filtering process helps with 
prediction, especially when predicting possible haplotypes in the plasma (less diversity), but 
consequently lower the chance to find fetal mutations. 
We tried to develop a fast and accurate method to predict fetal DNA based on single 
sample of blood (taken from pregnant woman). We succeeded in keeping it fast and obtained 
main purpose of predicting genotypes. However the accuracy is something that requires some 
work. Potential ways to achieve some improvement would be: 1) make more complete 
haplotypes. The predicted genotypes are reconstructed from both parental haplotypes. If any of 
the predicted haplotypes have gaps it will directly affect reconstructed SNPs; 2) find a way to 
calculate the fetal DNA concentration that is not dependent on sex chromosomes. It will greatly 
improve the accuracy of finding paternal haplotypes; 3) improving filtering criteria for SNPs 
included in the analysis. If a distinguishable difference is found between SNPs that were 
predicted accurately and mistakenly, that will certainly reveal the hidden issues that can be 
further corrected or help to exclude bad SNPs from the analysis from the start. For example it 
helped us to abandon the idea of recovering some SNPs called in mother, but not in father or 
fetus. We were able to newly assign 539 paternal and 408 fetal SNPs as homozygous by 
reference, but those SNPs did not add any significant contribution to correctly predicted SNPs, 
but mainly increased pool of predicted SNPs with only one correctly guessed allele. 
My dissertation work presents a new approach of reconstructing fetal DNA from 
maternal plasma. The method works because plasma from pregnant women, which contains 
“cell-free DNA”, has been noted to contain fetal DNA as well as maternal DNA. I developed and 
tested a workflow that implements my suggested approach. The workflow was broken into 
several parts, each fully documented in this dissertation. Each step we have taken was supported 
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with explanation of the logic driving the step. The approach works through the examination of 
sequencing data sets generated by short-read sequencing (also known as next-generation 
sequencing), by calling variation (single nucleotide polymorphisms, or SNPs) within those 
samples vis-à-vis a reference sequence. I developed and introduced a series of quality control 
criteria applied to SNPs to improve overall prediction. A novel single individual haplotyping 
method was developed and applied to haplotype the parental samples. The obtained parental 
haplotypes were incorporated into the workflow and along with parental genotypes were used to 
find transmitted haplotypes in the maternal plasma. The predicted haplotypes were then aligned 
to each other to obtain phased SNPs. For evaluation, I compared fetal SNPs predicted by my 
method against control fetal SNPs (from sequencing of fetal DNA). Overall prediction power is 
discussed. Possible ways of improvements that should affect the overall prediction are also 
described. 
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